This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
To LB, Haylock DN, Simmons PL et al. The biology and clinical uses of blood stem cells Blood 1997 89: 2233–2258
Salazar R, Sola C, Marto P et al. Factors affecting CD34+ cell mobilization with with cyclophosphamide and G-CSF and haematopoietic recovery after high-dose chemotherapy and stem cell support in solid tumour patients Proc ASCO 1998 17: 95a
Lee CK, Gingrich, RD, Hohl RJ, Ajram-KA . Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation Bone Marrow Transplant 1995 16: 175–182
Ravoet C, Feremans W, Husson B et al. Clinical evidence for an engraftment syndrome associated with early and steep neutrophil recovery after autologous blood stem cell transplantation Bone Marrow Transplant 1996 18: 943–947
Rabitsch W, Staudinger T, Brugger SA et al. Successful management of adult respiratory distress syndrome (ARDS) after high-dose chemotherapy and peripheral blood progenitor cell rescue by non-invasive ventilatory support Bone Marrow Transplant 1998 21: 1067–1069
Niitsu N, Iki S, Muroi K et al. Interstitial pneumonia in patients receiving granulocyte colony-stimulating factor during chemotherapy: survey in Japan 1991–96 Br J Cancer 1997 76: 1661–1666
Ohsaka A, Kitagawa S, Sakamoto S et al. In vivo activation of human neutrophil functions by administration of recombinant human granulocyte colony-stimulating factor in patients with malignant lymphoma Blood 1989 74: 2743–2748
Ericson SG, Zhao Y, Gao H et al. Interleukin-6 production by human neutrophils after Fc-receptor cross-linking or exposure to granulocyte colony-stimulating factor Blood 1998 91: 2099–2107
Colby C, McAfee SL, Finkelstein, DM et al. Early vs delayed administration of G-CSF following autologous peripheral blood stem cell transplantation Bone Marrow Transplant 1998 21: 1005–1010
Kawano Y, Takaue Y, Mimaya J et al. Marginal benefit/disadvantage of granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation in children: results of a prospective randomized trial. The Japanese Cooperative Study Group of PBSCT Blood 1998 92: 4040–4046
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kawano, C., Muroi, K., Kuribara, R. et al. Engraftment syndrome after autologous peripheral blood stem cell transplantation with high numbers of peripheral blood stem cells followed by granulocyte colony-stimulating factor administration. Bone Marrow Transplant 25, 228–229 (2000). https://doi.org/10.1038/sj.bmt.1702110
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702110
This article is cited by
-
Prior anti-PD-1 therapy as a risk factor for life-threatening peri-engraftment respiratory distress syndrome in patients undergoing autologous stem cell transplantation
Bone Marrow Transplantation (2021)
-
Improving security of autologous hematopoietic stem cell transplant in patients with light-chain amyloidosis
Bone Marrow Transplantation (2019)
-
Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation
Bone Marrow Transplantation (2018)
-
Engraftment syndrome after autologous hematopoietic stem cell transplant supported by granulocyte-colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor (GM-CSF)
Bone Marrow Transplantation (2003)
-
Engraftment syndrome: a common cause for rash and fever following autologous hematopoietic stem cell transplantation for multiple sclerosis
Bone Marrow Transplantation (2002)